BAART Programs St. Albans celebrates 20 years of service from medical director

Posted

ST. ALBANS — BAART Programs St. Albans is proud to honor Dr. John Brooklyn, medical director, as he celebrates 20 years of service to patients and the broader St. Albans community.

Since joining BAART Programs in 2005, Dr. Brooklyn has provided two decades of compassionate, patient-centered care for individuals seeking recovery from opioid use disorder. This year alone, he has treated and supported approximately 500 patients on their path to recovery. His leadership has been instrumental in expanding access to treatment and fostering strong relationships with local partners, making a meaningful impact not only within the clinic but throughout the community.

“Dr. Brooklyn has dedicated his career to helping people find hope and healing,” said Nick Martin, treatment center director. “We are honored to celebrate his 20 years of service and the countless lives he has touched in St. Albans and beyond.”

Dr. John Brooklyn, board certified in family and addiction medicine, is a nationally-recognized leader in opioid use disorder treatment. He developed Vermont’s Hub and Spoke model, contributed to the FDA approval of buprenorphine and has been active in clinical research since 1992.

As a national mentor and trainer, he educates healthcare professionals across the country. His work spans primary care, behavioral health, mindfulness and substance use treatment. This anniversary celebrates his unwavering commitment to improving the health and well-being of Vermonters through evidence-based care and community collaboration.

Located at 242 South Main Street in St. Albans, BAART Programs offers compassionate outpatient treatment for opioid use disorders — serving individuals grappling with addiction to fentanyl, heroin or prescription painkillers. They provide medication-assisted treatment with methadone and buprenorphine along with counseling, tailored to each person’s unique recovery needs. To learn more, visit BAARTPrograms.com.

Comments

No comments on this item Please log in to comment by clicking here